Financials Naba Al Saha Medical Services Company

Equities

9546

SA15K0SKL513

Healthcare Facilities & Services

Delayed Saudi Arabian S.E. 03:26:11 2024-05-29 am EDT 5-day change 1st Jan Change
85.2 SAR -2.07% Intraday chart for Naba Al Saha Medical Services Company -3.73% +42.00%

Valuation

Fiscal Period: December 2022
Capitalization 1 301
Enterprise Value (EV) 1 309.2
P/E ratio 11.2 x
Yield 0.7%
Capitalization / Revenue 2.32 x
EV / Revenue 2.38 x
EV / EBITDA 8.97 x
EV / FCF 19,769,559 x
FCF Yield 0%
Price to Book 2.32 x
Nbr of stocks (in thousands) 10,500
Reference price 2 28.67
Announcement Date 4/4/23
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 115.7 117.7 129.7
EBITDA 1 32.18 31.5 34.49
EBIT 1 27.57 26.85 29.29
Operating Margin 23.83% 22.82% 22.59%
Earnings before Tax (EBT) 1 28.34 27.53 28.93
Net income 1 26.65 25.83 26.92
Net margin 23.04% 21.95% 20.76%
EPS - 2.460 2.564
Free Cash Flow - 14.29 15.64
FCF margin - 12.14% 12.06%
FCF Conversion (EBITDA) - 45.36% 45.36%
FCF Conversion (Net income) - 55.33% 58.1%
Dividend per Share - 0.2000 0.2000
Announcement Date 7/31/22 7/31/22 4/4/23
1SAR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 47.5 26.3 8.24
Net Cash position 1 - - -
Leverage (Debt/EBITDA) 1.478 x 0.8349 x 0.2391 x
Free Cash Flow - 14.3 15.6
ROE (net income / shareholders' equity) - 28.5% 23.1%
ROA (Net income/ Total Assets) - 11.1% 11.1%
Assets 1 - 233.5 241.7
Book Value Per Share - 9.800 12.40
Cash Flow per Share - 0.6700 1.320
Capex 1 39.6 10.4 7.55
Capex / Sales 34.27% 8.81% 5.82%
Announcement Date 7/31/22 7/31/22 4/4/23
1SAR in Million
Estimates
  1. Stock Market
  2. Equities
  3. 9546 Stock
  4. Financials Naba Al Saha Medical Services Company